nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC22A2—Cladribine—multiple sclerosis	0.211	0.535	CbGbCtD
Amiloride—SLC22A1—Cladribine—multiple sclerosis	0.183	0.465	CbGbCtD
Amiloride—ASIC2—peripheral nervous system—multiple sclerosis	0.0353	0.188	CbGeAlD
Amiloride—ASIC2—nerve—multiple sclerosis	0.0275	0.147	CbGeAlD
Amiloride—PLAU—amb2 Integrin signaling—SELPLG—multiple sclerosis	0.0111	0.058	CbGpPWpGaD
Amiloride—ASIC2—medulla oblongata—multiple sclerosis	0.00823	0.0439	CbGeAlD
Amiloride—SLC9A1—Osteoclast Signaling—IFNB1—multiple sclerosis	0.00667	0.035	CbGpPWpGaD
Amiloride—ASIC2—nervous system—multiple sclerosis	0.00618	0.033	CbGeAlD
Amiloride—ASIC2—central nervous system—multiple sclerosis	0.00595	0.0318	CbGeAlD
Amiloride—ASIC2—cerebellum—multiple sclerosis	0.00582	0.0311	CbGeAlD
Amiloride—PLAU—Beta5 beta6 beta7 and beta8 integrin cell surface interactions—ITGA4—multiple sclerosis	0.00578	0.0303	CbGpPWpGaD
Amiloride—ASIC1—medulla oblongata—multiple sclerosis	0.0052	0.0278	CbGeAlD
Amiloride—PLAU—ATF-2 transcription factor network—IL23A—multiple sclerosis	0.00514	0.0269	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—SPP1—multiple sclerosis	0.0051	0.0267	CbGpPWpGaD
Amiloride—PLAU—Beta5 beta6 beta7 and beta8 integrin cell surface interactions—VCAM1—multiple sclerosis	0.00502	0.0263	CbGpPWpGaD
Amiloride—SLC9A1—Osteoclast Signaling—SPP1—multiple sclerosis	0.00479	0.0251	CbGpPWpGaD
Amiloride—ASIC1—midbrain—multiple sclerosis	0.00476	0.0254	CbGeAlD
Amiloride—ASIC2—brain—multiple sclerosis	0.00472	0.0252	CbGeAlD
Amiloride—ASIC1—spinal cord—multiple sclerosis	0.00464	0.0248	CbGeAlD
Amiloride—SLC9A1—midbrain—multiple sclerosis	0.00456	0.0243	CbGeAlD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00419	0.0219	CbGpPWpGaD
Amiloride—SCNN1D—nervous system—multiple sclerosis	0.00398	0.0213	CbGeAlD
Amiloride—ASIC1—nervous system—multiple sclerosis	0.00391	0.0209	CbGeAlD
Amiloride—SCNN1D—central nervous system—multiple sclerosis	0.00383	0.0205	CbGeAlD
Amiloride—ASIC1—central nervous system—multiple sclerosis	0.00376	0.0201	CbGeAlD
Amiloride—SCNN1G—cerebellum—multiple sclerosis	0.00375	0.02	CbGeAlD
Amiloride—SCNN1D—cerebellum—multiple sclerosis	0.00375	0.02	CbGeAlD
Amiloride—SLC9A1—nervous system—multiple sclerosis	0.00374	0.02	CbGeAlD
Amiloride—ASIC1—cerebellum—multiple sclerosis	0.00368	0.0196	CbGeAlD
Amiloride—SLC9A1—central nervous system—multiple sclerosis	0.00361	0.0193	CbGeAlD
Amiloride—PLAU—nervous system—multiple sclerosis	0.00355	0.019	CbGeAlD
Amiloride—SLC9A1—cerebellum—multiple sclerosis	0.00352	0.0188	CbGeAlD
Amiloride—PLAU—central nervous system—multiple sclerosis	0.00342	0.0182	CbGeAlD
Amiloride—SCNN1B—nervous system—multiple sclerosis	0.00337	0.018	CbGeAlD
Amiloride—PLAU—E2F transcription factor network—RRM1—multiple sclerosis	0.00329	0.0172	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—VCAM1—multiple sclerosis	0.00328	0.0172	CbGpPWpGaD
Amiloride—SCNN1B—central nervous system—multiple sclerosis	0.00324	0.0173	CbGeAlD
Amiloride—SCNN1D—brain—multiple sclerosis	0.00304	0.0163	CbGeAlD
Amiloride—ASIC1—brain—multiple sclerosis	0.00299	0.016	CbGeAlD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—GPC5—multiple sclerosis	0.00297	0.0156	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—SELE—multiple sclerosis	0.00295	0.0155	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—CD40LG—multiple sclerosis	0.00289	0.0151	CbGpPWpGaD
Amiloride—SLC9A1—brain—multiple sclerosis	0.00286	0.0153	CbGeAlD
Amiloride—PLAU—Osteopontin Signaling—MMP9—multiple sclerosis	0.00271	0.0142	CbGpPWpGaD
Amiloride—PLAU—brain—multiple sclerosis	0.00271	0.0145	CbGeAlD
Amiloride—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00266	0.0139	CbGpPWpGaD
Amiloride—SCNN1B—brain—multiple sclerosis	0.00257	0.0137	CbGeAlD
Amiloride—PLAU—Osteopontin-mediated events—SPP1—multiple sclerosis	0.00255	0.0133	CbGpPWpGaD
Amiloride—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00247	0.013	CbGpPWpGaD
Amiloride—SCNN1A—brain—multiple sclerosis	0.00238	0.0127	CbGeAlD
Amiloride—PLAU—Beta2 integrin cell surface interactions—ICAM1—multiple sclerosis	0.00223	0.0117	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—MAPK1—multiple sclerosis	0.00219	0.0115	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—ICAM1—multiple sclerosis	0.00206	0.0108	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—SPP1—multiple sclerosis	0.00196	0.0103	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—ITGA4—multiple sclerosis	0.00195	0.0102	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.0019	0.00997	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00187	0.0098	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IRF5—multiple sclerosis	0.00183	0.00959	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—VCAM1—multiple sclerosis	0.0017	0.00889	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—multiple sclerosis	0.00164	0.00861	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—SPP1—multiple sclerosis	0.00163	0.00855	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CCL3—multiple sclerosis	0.0016	0.00839	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—GPC5—multiple sclerosis	0.0016	0.00836	CbGpPWpGaD
Amiloride—SLC22A4—spinal cord—multiple sclerosis	0.00148	0.00789	CbGeAlD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00144	0.00756	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00144	0.00756	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00144	0.00756	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00144	0.00756	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00144	0.00756	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00144	0.00756	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00143	0.00748	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL10—multiple sclerosis	0.00143	0.00747	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—SPP1—multiple sclerosis	0.00143	0.00747	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00142	0.00743	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—SPP1—multiple sclerosis	0.00139	0.00728	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL4—multiple sclerosis	0.00139	0.00727	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP9—multiple sclerosis	0.00135	0.00709	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IFNB1—multiple sclerosis	0.00134	0.007	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—MMP9—multiple sclerosis	0.00132	0.00691	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—HLA-A—multiple sclerosis	0.00126	0.00659	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MERTK—multiple sclerosis	0.00122	0.00637	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CD58—multiple sclerosis	0.00122	0.00637	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SELPLG—multiple sclerosis	0.00122	0.00637	CbGpPWpGaD
Amiloride—SLC22A1—nervous system—multiple sclerosis	0.00119	0.00633	CbGeAlD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—multiple sclerosis	0.00118	0.00616	CbGpPWpGaD
Amiloride—SLC22A4—cerebellum—multiple sclerosis	0.00117	0.00626	CbGeAlD
Amiloride—SLC22A1—central nervous system—multiple sclerosis	0.00114	0.0061	CbGeAlD
Amiloride—ASIC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00114	0.00597	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MAPK1—multiple sclerosis	0.00109	0.00573	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00109	0.00573	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00109	0.00573	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00109	0.00573	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00109	0.00573	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00109	0.00573	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—multiple sclerosis	0.00106	0.00556	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00105	0.105	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Methylprednisolone—multiple sclerosis	0.00105	0.105	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Betamethasone—multiple sclerosis	0.00103	0.104	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Dexamethasone—multiple sclerosis	0.00103	0.104	CbGdCrCtD
Amiloride—PLAU—amb2 Integrin signaling—TNF—multiple sclerosis	0.00102	0.00532	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00101	0.00528	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Triamcinolone—multiple sclerosis	0.00101	0.101	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Triamcinolone—multiple sclerosis	0.00101	0.101	CbGdCrCtD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000998	0.00523	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000991	0.00519	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CCL2—multiple sclerosis	0.000987	0.00517	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.000962	0.00504	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Prednisone—multiple sclerosis	0.000954	0.0961	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisone—multiple sclerosis	0.000954	0.0961	CbGdCrCtD
Amiloride—SLC22A4—brain—multiple sclerosis	0.000952	0.00508	CbGeAlD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000951	0.00498	CbGpPWpGaD
Amiloride—PLAU—Betamethasone—Prednisolone—multiple sclerosis	0.000932	0.0938	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Prednisolone—multiple sclerosis	0.000932	0.0938	CbGdCrCtD
Amiloride—SLC22A1—brain—multiple sclerosis	0.000907	0.00484	CbGeAlD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—multiple sclerosis	0.000875	0.00458	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—MMP9—multiple sclerosis	0.000868	0.00455	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000864	0.00453	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000864	0.00453	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000864	0.00453	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000864	0.00453	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000864	0.00453	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000856	0.00449	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IFNG—multiple sclerosis	0.000839	0.0044	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—IL6—multiple sclerosis	0.00082	0.00429	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—STAT3—multiple sclerosis	0.000772	0.00405	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000764	0.004	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000764	0.004	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000764	0.004	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000764	0.004	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000764	0.004	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—MMP9—multiple sclerosis	0.000758	0.00397	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PLEK—multiple sclerosis	0.000751	0.00393	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL2—multiple sclerosis	0.000746	0.00391	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—multiple sclerosis	0.00073	0.00382	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000721	0.00378	CbGpPWpGaD
Amiloride—Constipation—Cladribine—multiple sclerosis	0.000716	0.00328	CcSEcCtD
Amiloride—Arthralgia—Azathioprine—multiple sclerosis	0.00071	0.00325	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MMP9—multiple sclerosis	0.000706	0.0037	CbGpPWpGaD
Amiloride—Coma—Methotrexate—multiple sclerosis	0.000702	0.00322	CcSEcCtD
Amiloride—PLAU—FGF signaling pathway—MAPK1—multiple sclerosis	0.000702	0.00368	CbGpPWpGaD
Amiloride—Urine output increased—Methotrexate—multiple sclerosis	0.000695	0.00318	CcSEcCtD
Amiloride—Feeling abnormal—Cladribine—multiple sclerosis	0.00069	0.00316	CcSEcCtD
Amiloride—SLC9A1—Endothelins—MAPK1—multiple sclerosis	0.000688	0.0036	CbGpPWpGaD
Amiloride—Gynaecomastia—Methotrexate—multiple sclerosis	0.000687	0.00315	CcSEcCtD
Amiloride—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000684	0.00314	CcSEcCtD
Amiloride—Alopecia—Mitoxantrone—multiple sclerosis	0.000684	0.00314	CcSEcCtD
Amiloride—Muscular weakness—Dexamethasone—multiple sclerosis	0.000676	0.0031	CcSEcCtD
Amiloride—Muscular weakness—Betamethasone—multiple sclerosis	0.000676	0.0031	CcSEcCtD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000676	0.00354	CbGpPWpGaD
Amiloride—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000667	0.00306	CcSEcCtD
Amiloride—Abdominal pain—Cladribine—multiple sclerosis	0.000662	0.00303	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000654	0.00343	CbGpPWpGaD
Amiloride—Back pain—Mitoxantrone—multiple sclerosis	0.000652	0.00299	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000649	0.0034	CbGpPWpGaD
Amiloride—Bradycardia—Prednisolone—multiple sclerosis	0.000647	0.00297	CcSEcCtD
Amiloride—Haemoglobin—Prednisolone—multiple sclerosis	0.000639	0.00293	CcSEcCtD
Amiloride—Haemorrhage—Prednisolone—multiple sclerosis	0.000635	0.00291	CcSEcCtD
Amiloride—Polyuria—Methotrexate—multiple sclerosis	0.000635	0.00291	CcSEcCtD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00063	0.0033	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—TGFB1—multiple sclerosis	0.000625	0.00327	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00062	0.00284	CcSEcCtD
Amiloride—Visual impairment—Prednisolone—multiple sclerosis	0.000612	0.00281	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IFNG—multiple sclerosis	0.000607	0.00318	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—MYC—multiple sclerosis	0.000604	0.00316	CbGpPWpGaD
Amiloride—Asthenia—Cladribine—multiple sclerosis	0.000601	0.00275	CcSEcCtD
Amiloride—Bradycardia—Triamcinolone—multiple sclerosis	0.000595	0.00273	CcSEcCtD
Amiloride—Bradycardia—Methylprednisolone—multiple sclerosis	0.000593	0.00272	CcSEcCtD
Amiloride—Pruritus—Cladribine—multiple sclerosis	0.000592	0.00271	CcSEcCtD
Amiloride—Muscular weakness—Prednisone—multiple sclerosis	0.000589	0.0027	CcSEcCtD
Amiloride—Visual disturbance—Methotrexate—multiple sclerosis	0.000589	0.0027	CcSEcCtD
Amiloride—Cough—Mitoxantrone—multiple sclerosis	0.000588	0.0027	CcSEcCtD
Amiloride—SLC9A1—Metabolism—SRM—multiple sclerosis	0.000588	0.00308	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000588	0.00269	CcSEcCtD
Amiloride—Haemoglobin—Triamcinolone—multiple sclerosis	0.000587	0.00269	CcSEcCtD
Amiloride—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000586	0.00269	CcSEcCtD
Amiloride—Haemorrhage—Triamcinolone—multiple sclerosis	0.000584	0.00268	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MYC—multiple sclerosis	0.000583	0.00305	CbGpPWpGaD
Amiloride—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000583	0.00267	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TGFB1—multiple sclerosis	0.000582	0.00305	CbGpPWpGaD
Amiloride—Abdominal distension—Prednisone—multiple sclerosis	0.000581	0.00266	CcSEcCtD
Amiloride—Arthralgia—Mitoxantrone—multiple sclerosis	0.000574	0.00263	CcSEcCtD
Amiloride—Chest pain—Mitoxantrone—multiple sclerosis	0.000574	0.00263	CcSEcCtD
Amiloride—Diarrhoea—Cladribine—multiple sclerosis	0.000573	0.00263	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00057	0.00298	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—MYC—multiple sclerosis	0.000564	0.00295	CbGpPWpGaD
Amiloride—Visual impairment—Methylprednisolone—multiple sclerosis	0.000562	0.00258	CcSEcCtD
Amiloride—Feeling abnormal—Azathioprine—multiple sclerosis	0.000561	0.00257	CcSEcCtD
Amiloride—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000557	0.00255	CcSEcCtD
Amiloride—Confusional state—Mitoxantrone—multiple sclerosis	0.000555	0.00254	CcSEcCtD
Amiloride—Dizziness—Cladribine—multiple sclerosis	0.000554	0.00254	CcSEcCtD
Amiloride—SLC22A2—Neuronal System—KCNA3—multiple sclerosis	0.000552	0.00289	CbGpPWpGaD
Amiloride—Shock—Mitoxantrone—multiple sclerosis	0.000541	0.00248	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1B—multiple sclerosis	0.000541	0.00283	CbGpPWpGaD
Amiloride—Bradycardia—Dexamethasone—multiple sclerosis	0.00054	0.00247	CcSEcCtD
Amiloride—Bradycardia—Betamethasone—multiple sclerosis	0.00054	0.00247	CcSEcCtD
Amiloride—Neutropenia—Prednisone—multiple sclerosis	0.000539	0.00247	CcSEcCtD
Amiloride—Abdominal pain—Azathioprine—multiple sclerosis	0.000538	0.00247	CcSEcCtD
Amiloride—Haemoglobin—Dexamethasone—multiple sclerosis	0.000533	0.00244	CcSEcCtD
Amiloride—Haemoglobin—Betamethasone—multiple sclerosis	0.000533	0.00244	CcSEcCtD
Amiloride—Vomiting—Cladribine—multiple sclerosis	0.000532	0.00244	CcSEcCtD
Amiloride—Erectile dysfunction—Prednisone—multiple sclerosis	0.000531	0.00244	CcSEcCtD
Amiloride—Haemorrhage—Dexamethasone—multiple sclerosis	0.00053	0.00243	CcSEcCtD
Amiloride—Haemorrhage—Betamethasone—multiple sclerosis	0.00053	0.00243	CcSEcCtD
Amiloride—PLAU—Hemostasis—SELE—multiple sclerosis	0.000529	0.00277	CbGpPWpGaD
Amiloride—Rash—Cladribine—multiple sclerosis	0.000528	0.00242	CcSEcCtD
Amiloride—Dermatitis—Cladribine—multiple sclerosis	0.000527	0.00242	CcSEcCtD
Amiloride—Anorexia—Mitoxantrone—multiple sclerosis	0.000524	0.0024	CcSEcCtD
Amiloride—Headache—Cladribine—multiple sclerosis	0.000524	0.0024	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—KCNA3—multiple sclerosis	0.000515	0.0027	CbGpPWpGaD
Amiloride—Depression—Prednisone—multiple sclerosis	0.000513	0.00235	CcSEcCtD
Amiloride—Visual impairment—Dexamethasone—multiple sclerosis	0.000511	0.00234	CcSEcCtD
Amiloride—Visual impairment—Betamethasone—multiple sclerosis	0.000511	0.00234	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000504	0.00264	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—STAT3—multiple sclerosis	0.000503	0.00263	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—multiple sclerosis	0.000502	0.00263	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000501	0.0023	CcSEcCtD
Amiloride—Nausea—Cladribine—multiple sclerosis	0.000497	0.00228	CcSEcCtD
Amiloride—Vertigo—Prednisolone—multiple sclerosis	0.000497	0.00228	CcSEcCtD
Amiloride—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000494	0.00226	CcSEcCtD
Amiloride—Back pain—Triamcinolone—multiple sclerosis	0.000492	0.00226	CcSEcCtD
Amiloride—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000491	0.00225	CcSEcCtD
Amiloride—Somnolence—Mitoxantrone—multiple sclerosis	0.000489	0.00224	CcSEcCtD
Amiloride—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000484	0.00222	CcSEcCtD
Amiloride—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000478	0.00219	CcSEcCtD
Amiloride—Fatigue—Mitoxantrone—multiple sclerosis	0.000474	0.00217	CcSEcCtD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000472	0.00247	CbGpPWpGaD
Amiloride—Constipation—Mitoxantrone—multiple sclerosis	0.00047	0.00216	CcSEcCtD
Amiloride—Pain—Mitoxantrone—multiple sclerosis	0.00047	0.00216	CcSEcCtD
Amiloride—Bradycardia—Prednisone—multiple sclerosis	0.00047	0.00215	CcSEcCtD
Amiloride—Alopecia—Betamethasone—multiple sclerosis	0.000468	0.00215	CcSEcCtD
Amiloride—Alopecia—Dexamethasone—multiple sclerosis	0.000468	0.00215	CcSEcCtD
Amiloride—Diarrhoea—Azathioprine—multiple sclerosis	0.000466	0.00213	CcSEcCtD
Amiloride—Haemoglobin—Prednisone—multiple sclerosis	0.000464	0.00213	CcSEcCtD
Amiloride—Haemorrhage—Prednisone—multiple sclerosis	0.000462	0.00212	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—MAPK1—multiple sclerosis	0.000457	0.00239	CbGpPWpGaD
Amiloride—Vertigo—Triamcinolone—multiple sclerosis	0.000457	0.00209	CcSEcCtD
Amiloride—Vertigo—Methylprednisolone—multiple sclerosis	0.000456	0.00209	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000454	0.00238	CbGpPWpGaD
Amiloride—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000453	0.00208	CcSEcCtD
Amiloride—SLC9A1—Disease—GPC5—multiple sclerosis	0.000452	0.00237	CbGpPWpGaD
Amiloride—Neutropenia—Methotrexate—multiple sclerosis	0.000451	0.00207	CcSEcCtD
Amiloride—Dysuria—Methotrexate—multiple sclerosis	0.000451	0.00207	CcSEcCtD
Amiloride—Dizziness—Azathioprine—multiple sclerosis	0.00045	0.00206	CcSEcCtD
Amiloride—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00045	0.00206	CcSEcCtD
Amiloride—Shock—Prednisolone—multiple sclerosis	0.000444	0.00204	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000444	0.00204	CcSEcCtD
Amiloride—Cough—Triamcinolone—multiple sclerosis	0.000444	0.00203	CcSEcCtD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00044	0.0023	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL6—multiple sclerosis	0.000438	0.0023	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000435	0.00228	CbGpPWpGaD
Amiloride—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000435	0.00199	CcSEcCtD
Amiloride—Vomiting—Azathioprine—multiple sclerosis	0.000433	0.00198	CcSEcCtD
Amiloride—Arthralgia—Methylprednisolone—multiple sclerosis	0.000432	0.00198	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—multiple sclerosis	0.000431	0.00226	CbGpPWpGaD
Amiloride—Rash—Azathioprine—multiple sclerosis	0.000429	0.00197	CcSEcCtD
Amiloride—Dermatitis—Azathioprine—multiple sclerosis	0.000429	0.00197	CcSEcCtD
Amiloride—Depression—Methotrexate—multiple sclerosis	0.000429	0.00196	CcSEcCtD
Amiloride—Headache—Azathioprine—multiple sclerosis	0.000426	0.00195	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TGFB1—multiple sclerosis	0.00042	0.0022	CbGpPWpGaD
Amiloride—Confusional state—Methylprednisolone—multiple sclerosis	0.000418	0.00191	CcSEcCtD
Amiloride—Vertigo—Betamethasone—multiple sclerosis	0.000415	0.0019	CcSEcCtD
Amiloride—Vertigo—Dexamethasone—multiple sclerosis	0.000415	0.0019	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CYP27B1—multiple sclerosis	0.000414	0.00217	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP24A1—multiple sclerosis	0.000414	0.00217	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—MAPK1—multiple sclerosis	0.000412	0.00216	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—multiple sclerosis	0.000409	0.00214	CbGpPWpGaD
Amiloride—Shock—Triamcinolone—multiple sclerosis	0.000408	0.00187	CcSEcCtD
Amiloride—Insomnia—Prednisolone—multiple sclerosis	0.000408	0.00187	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TGFB1—multiple sclerosis	0.000408	0.00214	CbGpPWpGaD
Amiloride—Alopecia—Prednisone—multiple sclerosis	0.000408	0.00187	CcSEcCtD
Amiloride—Shock—Methylprednisolone—multiple sclerosis	0.000407	0.00187	CcSEcCtD
Amiloride—Paraesthesia—Prednisolone—multiple sclerosis	0.000405	0.00186	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000405	0.00212	CbGpPWpGaD
Amiloride—Nausea—Azathioprine—multiple sclerosis	0.000404	0.00185	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MAPK1—multiple sclerosis	0.0004	0.0021	CbGpPWpGaD
Amiloride—Asthenia—Mitoxantrone—multiple sclerosis	0.000395	0.00181	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—multiple sclerosis	0.000388	0.00178	CcSEcCtD
Amiloride—Pain—Prednisolone—multiple sclerosis	0.000386	0.00177	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—multiple sclerosis	0.000386	0.00177	CcSEcCtD
Amiloride—PLAU—Hemostasis—ITGA4—multiple sclerosis	0.000383	0.002	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IFNB1—multiple sclerosis	0.00038	0.00199	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPC5—multiple sclerosis	0.000379	0.00198	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000378	0.00173	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000378	0.00198	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000377	0.00173	CcSEcCtD
Amiloride—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000376	0.00173	CcSEcCtD
Amiloride—Insomnia—Triamcinolone—multiple sclerosis	0.000375	0.00172	CcSEcCtD
Amiloride—Insomnia—Methylprednisolone—multiple sclerosis	0.000375	0.00172	CcSEcCtD
Amiloride—Paraesthesia—Triamcinolone—multiple sclerosis	0.000373	0.00171	CcSEcCtD
Amiloride—Feeling abnormal—Prednisolone—multiple sclerosis	0.000372	0.00171	CcSEcCtD
Amiloride—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000372	0.0017	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—multiple sclerosis	0.000372	0.0017	CcSEcCtD
Amiloride—Shock—Dexamethasone—multiple sclerosis	0.000371	0.0017	CcSEcCtD
Amiloride—Shock—Betamethasone—multiple sclerosis	0.000371	0.0017	CcSEcCtD
Amiloride—Dyspnoea—Triamcinolone—multiple sclerosis	0.00037	0.0017	CcSEcCtD
Amiloride—Dyspepsia—Triamcinolone—multiple sclerosis	0.000365	0.00168	CcSEcCtD
Amiloride—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000365	0.00167	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000363	0.0019	CbGpPWpGaD
Amiloride—Vertigo—Prednisone—multiple sclerosis	0.000361	0.00166	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—multiple sclerosis	0.00036	0.00165	CcSEcCtD
Amiloride—Anorexia—Betamethasone—multiple sclerosis	0.000359	0.00165	CcSEcCtD
Amiloride—Anorexia—Dexamethasone—multiple sclerosis	0.000359	0.00165	CcSEcCtD
Amiloride—Fatigue—Triamcinolone—multiple sclerosis	0.000358	0.00164	CcSEcCtD
Amiloride—Fatigue—Methylprednisolone—multiple sclerosis	0.000357	0.00164	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000357	0.00187	CbGpPWpGaD
Amiloride—Pain—Triamcinolone—multiple sclerosis	0.000355	0.00163	CcSEcCtD
Amiloride—Vomiting—Mitoxantrone—multiple sclerosis	0.00035	0.0016	CcSEcCtD
Amiloride—Rash—Mitoxantrone—multiple sclerosis	0.000347	0.00159	CcSEcCtD
Amiloride—Dermatitis—Mitoxantrone—multiple sclerosis	0.000347	0.00159	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000346	0.00181	CbGpPWpGaD
Amiloride—Headache—Mitoxantrone—multiple sclerosis	0.000345	0.00158	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000343	0.00157	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000343	0.00157	CcSEcCtD
Amiloride—Arthralgia—Prednisone—multiple sclerosis	0.000342	0.00157	CcSEcCtD
Amiloride—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000342	0.00157	CcSEcCtD
Amiloride—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000341	0.00156	CcSEcCtD
Amiloride—Alopecia—Methotrexate—multiple sclerosis	0.000341	0.00156	CcSEcCtD
Amiloride—Insomnia—Betamethasone—multiple sclerosis	0.000341	0.00156	CcSEcCtD
Amiloride—Insomnia—Dexamethasone—multiple sclerosis	0.000341	0.00156	CcSEcCtD
Amiloride—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000339	0.00155	CcSEcCtD
Amiloride—Paraesthesia—Betamethasone—multiple sclerosis	0.000338	0.00155	CcSEcCtD
Amiloride—Paraesthesia—Dexamethasone—multiple sclerosis	0.000338	0.00155	CcSEcCtD
Amiloride—Dyspepsia—Dexamethasone—multiple sclerosis	0.000332	0.00152	CcSEcCtD
Amiloride—Dyspepsia—Betamethasone—multiple sclerosis	0.000332	0.00152	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00033	0.00173	CbGpPWpGaD
Amiloride—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000327	0.0015	CcSEcCtD
Amiloride—Decreased appetite—Dexamethasone—multiple sclerosis	0.000327	0.0015	CcSEcCtD
Amiloride—Decreased appetite—Betamethasone—multiple sclerosis	0.000327	0.0015	CcSEcCtD
Amiloride—Nausea—Mitoxantrone—multiple sclerosis	0.000327	0.0015	CcSEcCtD
Amiloride—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000325	0.00149	CcSEcCtD
Amiloride—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000325	0.00149	CcSEcCtD
Amiloride—Back pain—Methotrexate—multiple sclerosis	0.000325	0.00149	CcSEcCtD
Amiloride—Fatigue—Betamethasone—multiple sclerosis	0.000325	0.00149	CcSEcCtD
Amiloride—Fatigue—Dexamethasone—multiple sclerosis	0.000325	0.00149	CcSEcCtD
Amiloride—Shock—Prednisone—multiple sclerosis	0.000323	0.00148	CcSEcCtD
Amiloride—Pain—Betamethasone—multiple sclerosis	0.000322	0.00148	CcSEcCtD
Amiloride—Pain—Dexamethasone—multiple sclerosis	0.000322	0.00148	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—multiple sclerosis	0.000317	0.00166	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—RRM1—multiple sclerosis	0.000314	0.00164	CbGpPWpGaD
Amiloride—Anorexia—Prednisone—multiple sclerosis	0.000313	0.00143	CcSEcCtD
Amiloride—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00031	0.00142	CcSEcCtD
Amiloride—Feeling abnormal—Betamethasone—multiple sclerosis	0.00031	0.00142	CcSEcCtD
Amiloride—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000308	0.00141	CcSEcCtD
Amiloride—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000308	0.00141	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000307	0.00161	CbGpPWpGaD
Amiloride—Vertigo—Methotrexate—multiple sclerosis	0.000302	0.00138	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000299	0.00137	CcSEcCtD
Amiloride—Dizziness—Prednisolone—multiple sclerosis	0.000298	0.00137	CcSEcCtD
Amiloride—Asthenia—Triamcinolone—multiple sclerosis	0.000298	0.00137	CcSEcCtD
Amiloride—Abdominal pain—Betamethasone—multiple sclerosis	0.000298	0.00136	CcSEcCtD
Amiloride—Abdominal pain—Dexamethasone—multiple sclerosis	0.000298	0.00136	CcSEcCtD
Amiloride—Asthenia—Methylprednisolone—multiple sclerosis	0.000297	0.00136	CcSEcCtD
Amiloride—Insomnia—Prednisone—multiple sclerosis	0.000297	0.00136	CcSEcCtD
Amiloride—Paraesthesia—Prednisone—multiple sclerosis	0.000295	0.00135	CcSEcCtD
Amiloride—SLC9A1—Disease—RPL5—multiple sclerosis	0.000294	0.00154	CbGpPWpGaD
Amiloride—Pruritus—Triamcinolone—multiple sclerosis	0.000294	0.00135	CcSEcCtD
Amiloride—Cough—Methotrexate—multiple sclerosis	0.000293	0.00134	CcSEcCtD
Amiloride—Pruritus—Methylprednisolone—multiple sclerosis	0.000293	0.00134	CcSEcCtD
Amiloride—Dyspepsia—Prednisone—multiple sclerosis	0.000289	0.00132	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000286	0.0015	CbGpPWpGaD
Amiloride—Arthralgia—Methotrexate—multiple sclerosis	0.000286	0.00131	CcSEcCtD
Amiloride—Chest pain—Methotrexate—multiple sclerosis	0.000286	0.00131	CcSEcCtD
Amiloride—Decreased appetite—Prednisone—multiple sclerosis	0.000285	0.00131	CcSEcCtD
Amiloride—Rash—Prednisolone—multiple sclerosis	0.000285	0.0013	CcSEcCtD
Amiloride—Dermatitis—Prednisolone—multiple sclerosis	0.000284	0.0013	CcSEcCtD
Amiloride—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000283	0.0013	CcSEcCtD
Amiloride—Fatigue—Prednisone—multiple sclerosis	0.000283	0.0013	CcSEcCtD
Amiloride—Headache—Prednisolone—multiple sclerosis	0.000283	0.0013	CcSEcCtD
Amiloride—SLC9A1—Disease—SLC11A1—multiple sclerosis	0.000282	0.00148	CbGpPWpGaD
Amiloride—Constipation—Prednisone—multiple sclerosis	0.00028	0.00129	CcSEcCtD
Amiloride—Confusional state—Methotrexate—multiple sclerosis	0.000276	0.00127	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000275	0.00144	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000275	0.00144	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000275	0.00144	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000275	0.00144	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000275	0.00144	CbGpPWpGaD
Amiloride—Dizziness—Triamcinolone—multiple sclerosis	0.000274	0.00126	CcSEcCtD
Amiloride—Dizziness—Methylprednisolone—multiple sclerosis	0.000274	0.00126	CcSEcCtD
Amiloride—Feeling abnormal—Prednisone—multiple sclerosis	0.00027	0.00124	CcSEcCtD
Amiloride—Asthenia—Betamethasone—multiple sclerosis	0.00027	0.00124	CcSEcCtD
Amiloride—Asthenia—Dexamethasone—multiple sclerosis	0.00027	0.00124	CcSEcCtD
Amiloride—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000268	0.00123	CcSEcCtD
Amiloride—Nausea—Prednisolone—multiple sclerosis	0.000268	0.00123	CcSEcCtD
Amiloride—Pruritus—Betamethasone—multiple sclerosis	0.000266	0.00122	CcSEcCtD
Amiloride—Pruritus—Dexamethasone—multiple sclerosis	0.000266	0.00122	CcSEcCtD
Amiloride—Vomiting—Triamcinolone—multiple sclerosis	0.000264	0.00121	CcSEcCtD
Amiloride—Vomiting—Methylprednisolone—multiple sclerosis	0.000263	0.00121	CcSEcCtD
Amiloride—Rash—Triamcinolone—multiple sclerosis	0.000262	0.0012	CcSEcCtD
Amiloride—Dermatitis—Triamcinolone—multiple sclerosis	0.000261	0.0012	CcSEcCtD
Amiloride—PLAU—Hemostasis—IL2RA—multiple sclerosis	0.000261	0.00137	CbGpPWpGaD
Amiloride—Anorexia—Methotrexate—multiple sclerosis	0.000261	0.0012	CcSEcCtD
Amiloride—Rash—Methylprednisolone—multiple sclerosis	0.000261	0.0012	CcSEcCtD
Amiloride—Dermatitis—Methylprednisolone—multiple sclerosis	0.000261	0.0012	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000261	0.00137	CbGpPWpGaD
Amiloride—Headache—Triamcinolone—multiple sclerosis	0.00026	0.00119	CcSEcCtD
Amiloride—Headache—Methylprednisolone—multiple sclerosis	0.000259	0.00119	CcSEcCtD
Amiloride—Abdominal pain—Prednisone—multiple sclerosis	0.000259	0.00119	CcSEcCtD
Amiloride—Diarrhoea—Dexamethasone—multiple sclerosis	0.000258	0.00118	CcSEcCtD
Amiloride—Diarrhoea—Betamethasone—multiple sclerosis	0.000258	0.00118	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00025	0.00114	CcSEcCtD
Amiloride—Dizziness—Dexamethasone—multiple sclerosis	0.000249	0.00114	CcSEcCtD
Amiloride—Dizziness—Betamethasone—multiple sclerosis	0.000249	0.00114	CcSEcCtD
Amiloride—Insomnia—Methotrexate—multiple sclerosis	0.000248	0.00114	CcSEcCtD
Amiloride—Nausea—Triamcinolone—multiple sclerosis	0.000247	0.00113	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—multiple sclerosis	0.000246	0.00113	CcSEcCtD
Amiloride—Nausea—Methylprednisolone—multiple sclerosis	0.000246	0.00113	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—multiple sclerosis	0.000244	0.00112	CcSEcCtD
Amiloride—Somnolence—Methotrexate—multiple sclerosis	0.000244	0.00112	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—multiple sclerosis	0.000241	0.00111	CcSEcCtD
Amiloride—Vomiting—Betamethasone—multiple sclerosis	0.000239	0.0011	CcSEcCtD
Amiloride—Vomiting—Dexamethasone—multiple sclerosis	0.000239	0.0011	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—multiple sclerosis	0.000238	0.00109	CcSEcCtD
Amiloride—Rash—Dexamethasone—multiple sclerosis	0.000237	0.00109	CcSEcCtD
Amiloride—Rash—Betamethasone—multiple sclerosis	0.000237	0.00109	CcSEcCtD
Amiloride—Dermatitis—Betamethasone—multiple sclerosis	0.000237	0.00109	CcSEcCtD
Amiloride—Dermatitis—Dexamethasone—multiple sclerosis	0.000237	0.00109	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000237	0.00108	CcSEcCtD
Amiloride—Fatigue—Methotrexate—multiple sclerosis	0.000236	0.00108	CcSEcCtD
Amiloride—Headache—Betamethasone—multiple sclerosis	0.000236	0.00108	CcSEcCtD
Amiloride—Headache—Dexamethasone—multiple sclerosis	0.000236	0.00108	CcSEcCtD
Amiloride—Asthenia—Prednisone—multiple sclerosis	0.000235	0.00108	CcSEcCtD
Amiloride—Pain—Methotrexate—multiple sclerosis	0.000234	0.00107	CcSEcCtD
Amiloride—Pruritus—Prednisone—multiple sclerosis	0.000232	0.00106	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00023	0.00121	CbGpPWpGaD
Amiloride—Feeling abnormal—Methotrexate—multiple sclerosis	0.000226	0.00104	CcSEcCtD
Amiloride—SLC9A1—Disease—CD28—multiple sclerosis	0.000225	0.00118	CbGpPWpGaD
Amiloride—Diarrhoea—Prednisone—multiple sclerosis	0.000224	0.00103	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000224	0.00103	CcSEcCtD
Amiloride—Nausea—Betamethasone—multiple sclerosis	0.000224	0.00103	CcSEcCtD
Amiloride—Nausea—Dexamethasone—multiple sclerosis	0.000224	0.00103	CcSEcCtD
Amiloride—Dizziness—Prednisone—multiple sclerosis	0.000217	0.000994	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—multiple sclerosis	0.000217	0.000993	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000215	0.00112	CbGpPWpGaD
Amiloride—Vomiting—Prednisone—multiple sclerosis	0.000209	0.000956	CcSEcCtD
Amiloride—Rash—Prednisone—multiple sclerosis	0.000207	0.000948	CcSEcCtD
Amiloride—Dermatitis—Prednisone—multiple sclerosis	0.000207	0.000947	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000206	0.00108	CbGpPWpGaD
Amiloride—Headache—Prednisone—multiple sclerosis	0.000205	0.000942	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000202	0.00106	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.0002	0.00105	CbGpPWpGaD
Amiloride—Asthenia—Methotrexate—multiple sclerosis	0.000197	0.000902	CcSEcCtD
Amiloride—Nausea—Prednisone—multiple sclerosis	0.000195	0.000893	CcSEcCtD
Amiloride—Pruritus—Methotrexate—multiple sclerosis	0.000194	0.000889	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000192	0.001	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—multiple sclerosis	0.000189	0.00099	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000188	0.000987	CbGpPWpGaD
Amiloride—Diarrhoea—Methotrexate—multiple sclerosis	0.000188	0.00086	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000181	0.00095	CbGpPWpGaD
Amiloride—Dizziness—Methotrexate—multiple sclerosis	0.000181	0.000831	CcSEcCtD
Amiloride—SLC9A1—Metabolism—BCHE—multiple sclerosis	0.00018	0.000944	CbGpPWpGaD
Amiloride—Vomiting—Methotrexate—multiple sclerosis	0.000174	0.000799	CcSEcCtD
Amiloride—Rash—Methotrexate—multiple sclerosis	0.000173	0.000792	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—multiple sclerosis	0.000173	0.000792	CcSEcCtD
Amiloride—Headache—Methotrexate—multiple sclerosis	0.000172	0.000787	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000163	0.000855	CbGpPWpGaD
Amiloride—Nausea—Methotrexate—multiple sclerosis	0.000163	0.000746	CcSEcCtD
Amiloride—SLC9A1—Disease—CD86—multiple sclerosis	0.00016	0.000841	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000156	0.000817	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BCHE—multiple sclerosis	0.000155	0.000812	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IL2—multiple sclerosis	0.000153	0.000803	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000145	0.000762	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BCHE—multiple sclerosis	0.000144	0.000756	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CCR5—multiple sclerosis	0.000142	0.000746	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HLA-A—multiple sclerosis	0.000139	0.000727	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—multiple sclerosis	0.000129	0.000678	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SRM—multiple sclerosis	0.000127	0.000666	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000123	0.000646	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—multiple sclerosis	0.00012	0.000626	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SRM—multiple sclerosis	0.000119	0.000621	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK1—multiple sclerosis	0.000117	0.000614	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD80—multiple sclerosis	0.000117	0.000613	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000115	0.000602	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000109	0.000571	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—multiple sclerosis	0.000108	0.000568	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000102	0.000532	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TYK2—multiple sclerosis	9.88e-05	0.000518	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—POMC—multiple sclerosis	9.31e-05	0.000488	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	8.96e-05	0.00047	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	8.96e-05	0.00047	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD4—multiple sclerosis	8.94e-05	0.000468	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—multiple sclerosis	8.49e-05	0.000445	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	8.35e-05	0.000438	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	8.35e-05	0.000438	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.3e-05	0.000435	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPC5—multiple sclerosis	8.2e-05	0.000429	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.72e-05	0.000405	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPC5—multiple sclerosis	7.64e-05	0.0004	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.2e-05	0.000377	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—multiple sclerosis	6.92e-05	0.000362	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RRM1—multiple sclerosis	6.79e-05	0.000356	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—multiple sclerosis	6.43e-05	0.000337	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—multiple sclerosis	6.41e-05	0.000336	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RRM1—multiple sclerosis	6.33e-05	0.000332	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK1—multiple sclerosis	6.29e-05	0.000329	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.91e-05	0.00031	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.51e-05	0.000289	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—multiple sclerosis	4.83e-05	0.000253	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	4.53e-05	0.000237	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	4.22e-05	0.000221	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.92e-05	0.000206	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BCHE—multiple sclerosis	3.9e-05	0.000204	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.66e-05	0.000192	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BCHE—multiple sclerosis	3.64e-05	0.00019	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—multiple sclerosis	2.35e-05	0.000123	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—multiple sclerosis	2.19e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—POMC—multiple sclerosis	2.02e-05	0.000106	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—POMC—multiple sclerosis	1.88e-05	9.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—multiple sclerosis	1.84e-05	9.63e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—multiple sclerosis	1.71e-05	8.97e-05	CbGpPWpGaD
